Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P29
Within normal range
vs 3Y Ago
-0.8x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-36.17%
202415.44%
202351.60%
202244.62%
20214262.42%
2020-97.13%
2019966.67%
2018-220.00%
2017-56.52%
2016470.97%